2020
DOI: 10.1101/2020.04.19.049569
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

TRIP6 is required for tension at adherens junctions

Abstract: Hippo signaling mediates influences of cytoskeletal tension on organ growth. TRIP6and LIMD1 have each been identified as being required for tension-dependent inhibition of the Hippo pathway LATS kinases and their recruitment to adherens junctions, but the relationship between TRIP6 and LIMD1 was unknown. Using siRNA-mediated gene knockdown we show that TRIP6 is required for LIMD1 localization to adherens junctions, whereas LIMD1 is not required for TRIP6 localization. TRIP6, but not LIMD1, is also required for… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
(54 reference statements)
0
1
0
Order By: Relevance
“…Mechanical forces at cell-cell junctions also control YAP/TAZ, as strain on epithelial monolayers induce β-catenin and YAP1 nuclear localization ( 62 , 63 ). Moreover, high tension inferred at the junctional cadherin-catenin complex, triggers the interaction of α-catenin with TRIP6 and LIMD1, which recruit LATS1/2 to the junctions and inhibit their kinase activity, leading to nuclear translocation of YAP/TAZ ( 64 66 ). The various Hippo and mechanotransduction pathways that regulate YAP/TAZ have been elegantly discussed previously ( 45 , 63 , 67 , 68 ).…”
Section: Molecular Regulation Of Yap/taz Activitymentioning
confidence: 99%
“…Mechanical forces at cell-cell junctions also control YAP/TAZ, as strain on epithelial monolayers induce β-catenin and YAP1 nuclear localization ( 62 , 63 ). Moreover, high tension inferred at the junctional cadherin-catenin complex, triggers the interaction of α-catenin with TRIP6 and LIMD1, which recruit LATS1/2 to the junctions and inhibit their kinase activity, leading to nuclear translocation of YAP/TAZ ( 64 66 ). The various Hippo and mechanotransduction pathways that regulate YAP/TAZ have been elegantly discussed previously ( 45 , 63 , 67 , 68 ).…”
Section: Molecular Regulation Of Yap/taz Activitymentioning
confidence: 99%